Blog
Expert Perspectives

Cardiology Blog

In-depth analysis, expert opinions, and clinical insights from leading cardiologists.

Featured Article

The Silent Epidemic: Why Cardiovascular Disease Remains the World's #1 Killer — And What We Can Do About It
Editor's Pick

The Silent Epidemic: Why Cardiovascular Disease Remains the World's #1 Killer — And What We Can Do About It

Despite decades of medical advances, cardiovascular disease claims more lives globally than any other condition. In this in-depth analysis, we explore the systemic, behavioral, and biological factors driving this epidemic — and the emerging strategies that offer real hope.

Dr. Sarah Chen, MD, FACC
May 14, 2026·12 min read
Read

Recent Articles

10 Evidence-Based Lifestyle Changes That Actually Reduce Cardiovascular Risk
Prevention

10 Evidence-Based Lifestyle Changes That Actually Reduce Cardiovascular Risk

From Mediterranean diet adherence to high-intensity interval training, we break down the interventions with the strongest clinical evidence for reducing heart disease risk.

Dr. Michael Torres, MD
May 12, 2026 8 min
AI in Cardiology: From ECG Interpretation to Predictive Risk Modeling
Technology

AI in Cardiology: From ECG Interpretation to Predictive Risk Modeling

Artificial intelligence is transforming how cardiologists diagnose, treat, and predict cardiovascular events. Here's a practical overview of what's clinically validated today.

Dr. Aisha Patel, PhD
May 10, 2026 10 min
Shared Decision-Making in Atrial Fibrillation: A Guide for Clinicians
Patient Care

Shared Decision-Making in Atrial Fibrillation: A Guide for Clinicians

How to effectively communicate stroke risk, anticoagulation benefits and risks, and rhythm versus rate control strategies with patients who have AF.

Dr. James Wilson, MD, FHRS
May 8, 2026 7 min
The DAPA-HF Trial: What 4 Years of Real-World Data Tells Us About Dapagliflozin
Research

The DAPA-HF Trial: What 4 Years of Real-World Data Tells Us About Dapagliflozin

Post-trial follow-up data from DAPA-HF continues to support the cardiovascular benefits of SGLT2 inhibitors in heart failure with reduced ejection fraction.

Dr. Elena Rodriguez, MD
May 6, 2026 9 min
Why Cardiologists Must Embrace Remote Patient Monitoring — Now
Opinion

Why Cardiologists Must Embrace Remote Patient Monitoring — Now

The evidence is clear: remote cardiac monitoring reduces hospitalizations, improves outcomes, and expands access to care. So why is adoption still lagging?

Dr. Robert Kim, MD, FACC
May 4, 2026 6 min
Understanding the New Heart Failure Classification: HFrEF, HFmrEF, and HFpEF
Education

Understanding the New Heart Failure Classification: HFrEF, HFmrEF, and HFpEF

A practical clinical guide to the updated heart failure phenotypes, their distinct pathophysiology, and the evidence-based treatment approaches for each.

Dr. Lisa Chang, MD
May 2, 2026 11 min